Skip to main content
. 2021 Aug 2;17(13):3369–3380. doi: 10.7150/ijbs.61439

Table 1.

M5C RNA methylation induced cell migration and metastasis

Cell type M5C component Role Effects Refs
Bladder urothelial carcinoma NSUN2 & YBX1 Writer & reader NSUN2 stabilize the mRNA of HDGF, while YBX1 bind to m5C methylation with a partner protein ELAVL1 and promote cell growth, tumor progression and metastasis 54
Breast cancer NSUN2 Writer NSUN2 overexpression promotes metastasis and invasion of breast cancer 109
Breast cancer NSUN6 Writer The antagonizing lncRNA for YAP activation inhibits activity of the protein serine kinase MST1 in a NSUN6-dependent way, which facilitates bone metastasis in breast cancer 125
ESCC NSUN2 Writer NSUN2 methylated lncRNA bind to chromatin regulator BPTF and promotes MMPs expression through ERK pathway 111
Glioma NSUN2 Writer NSUN2 deficiency inhibits glioma cell migration by striking autotaxin and lysophosphatidic acid associated pathway 100
HCC NSUN2 Writer NSUN2 methylated H19 bind to oncoprotein G3BP1, which may be associated with tumor genesis, migration and invasion 113
HEK 293 cell NSUN2 Writer NSUN2 promote cell proliferation and migration by regulating oncogenes that are associated with cell cycle, focal adhesion, TGF-β signaling pathway and Notch signaling pathway 52, 128
HNSCC NSUN5 & ALYREF Writer & reader ALYREF and NSUN5 are overexpressed in metastasis stage of head and neck squamous cell carcinoma 119
Neuroepithelial stem cells NSUN2 Writer NSUN2 mediate FGF2 induced migration and differentiation of neuroepithelial stem cells 106
Prostate and breast cancer NSUN2 Writer Expression level of NSUN2 and NSUN3 are regulated by proto-oncogenic isozymes (sphingosine kinases 1 and 2) in prostate metastasis cancer and breast cancer, by a possible mediation of epidermal growth factor associated cell migration 126
Prostate cancer DNMTs Writer DNMT1, DNMT2, and DNMT3 are involeved in lymph node metastases of prostate cancer 144

M5C writers and readers function as promoters of metastasis in pan-cancer. ESCC, esophageal squamous cell carcinoma. HCC, hepatocellular carcinoma. HNSCC, head and neck squamous cell carcinoma